Renal Anemia Solutions — Today's Advancements

H2 tag- SEO Purpose

Renal Anemia Solutions — Today's Advancements, Anemia, Cresp, Nephrology, Nephrologist, CKD, Dialysis,

 This article is brought to you by Cresp   

Renal Anemia Pharmacotherapy
Renal Anemia Pharmacotherapy
Advantages of treating renal anemia
Advantages of treating renal anemia
Erythropoiesis Stimulating Agents
Erythropoiesis Stimulating Agents
KDIGO
KDIGO
Advantages and Disadvantages of ESAs
Advantages and Disadvantages of ESAs
Hypoxia-inducible Factor Inhibitors
Hypoxia-inducible Factor Inhibitors
Iron supplementation
Iron supplementation
KDIGO 2012 Anemia Guideline
KDIGO 2012 Anemia Guideline
New Therapeutic Strategies in Renal Anemia
New Therapeutic Strategies in Renal Anemia

Abbreviations

CKD: Chronic kidney disease; EPO: Erythropoietin; ESA: Erythropoiesis stimulating agent; Hb: Haemoglobin; RBC: Red blood cell; TSAT: Transferrin saturation.

References

1. Borawski B, Malyszko JS, Kwiatkowska M, et al. Current Status of Renal Anemia Pharmacotherapy-What Can We Offer Today. J Clin Med. 2021;10(18):4149. 2. Chen N, Xing C, Niu J, et al. Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail. Chronic Dis Transl Med. 2022 Mar 29;8(1):59–70 3. Shoji S, Inaba M, Tomosugi N, et al. Greater potency of darbepoetin- than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients. Eur J Haematol. 2013;90(3):237–244.

LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0782

 

Cresp 1

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Cresp